buprenorphine
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FILM, BUCCAL | see comments below for restrictions | |||||||||||
| FILM, EXTENDED RELEASE, TRANSDERMAL | 5 mcg/hr | see comments below for restrictions | ||||||||||
| SOLUTION, EXTENDED RELEASE, SUBCUTANEOUS | 1; 8 mg/0.16 mL | see comments below for restrictions (Brixadi/Sublocade) | ||||||||||
| SOLUTION, INJECTABLE | 0.3 mg/mL | see comments below for restrictions (IV Bup) | ||||||||||
| TABLET, SUBLINGUAL | 2 mg; 8 mg |
| Drug Brand | Formulation | Restrictions |
| Belbuca | Film | None |
| Brixadi | SubQ (extended release) | Restricted to continuation of home med or ER initiation |
| Buprenorphine Injection | Injection | Restricted to psychiatry or toxicology |
| Butrans | Patch | Restricted to toxicology, psych, or continuation of home med |
| Sublocade | SubQ (extended release) | Restricted to continuation of home med or ER initiation |
| Suboxone | Film | Non-formulary |
| Zubsolv | Film | Restricted to toxicology, psych, or continuation of home med |